Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small cell lung cancer: A multicentre, open-label, randomized phase III study

被引:2
作者
Lu, S. [1 ]
Zhou, J. [2 ]
Jian, H. [1 ]
Wu, L. [3 ]
Cheng, Y. [4 ]
Fan, Y. [5 ]
Fang, J. [6 ]
Chen, G. [7 ]
Zhang, Z. [8 ]
Lv, D. [9 ]
Jiang, L. [10 ]
Wu, R. [11 ]
Jin, X. [12 ]
Zhang, X. [13 ]
Zhang, J. [14 ]
Sun, G. [15 ]
Huang, D. [16 ]
Cui, J. [17 ]
Guo, R. [18 ]
Ding, L. [19 ]
机构
[1] Shanghai Chest Hosp, Dept Oncol, Shanghai, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Resp Med, Hangzhou, Peoples R China
[3] Hunan Canc Hosp, Dept Thorac Med Oncol, Changsha, Peoples R China
[4] Jilin Canc Hosp, Dept Oncol, Changchun, Peoples R China
[5] Univ Chinese Acad Sci, Thorac Med Oncol, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[6] Beijing Canc Hosp, Beijing, Peoples R China
[7] Harbin Med Univ, Tumor Hosp, Dept Resp Med Oncol, Harbin, Peoples R China
[8] Anhui Prov Canc Hosp, Depertment Med Resp, Hefei, Peoples R China
[9] Taizhou Hosp Zhejiang Prov, Breath Internal Med, Taizhou, Peoples R China
[10] Shanghai Chest Hosp, Dept Resp Med, Shanghai, Peoples R China
[11] China Med Univ, ShengJing Hosp, Oncol Ward 2, Shenyang, Peoples R China
[12] Ningxia Med Univ, Gen Hosp, Dept Oncol, Yinchuan, Ningxia, Peoples R China
[13] Nantong Tumor Hosp, Internal Med Oncol, Nantong, Peoples R China
[14] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Peoples R China
[15] Anhui Med Univ, Affiliated Hosp 1, Depertment Med Resp, Hefei, Peoples R China
[16] Liuzhou Workers Hosp, Dept Med Oncol, Liuzhou, Peoples R China
[17] First Hosp Jilin Univ, Dept Oncol, Changchun, Peoples R China
[18] Jiangsu Prov Hosp, Dept Oncol, Nanjing, Peoples R China
[19] Betta Pharmaceut Co Ltd, Dept Med, Hangzhou, Peoples R China
关键词
D O I
10.1016/j.annonc.2022.10.333
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA6
引用
收藏
页码:S1553 / S1553
页数:1
相关论文
empty
未找到相关数据